Associated Papers
The Impact of IL-6 and IL-10 Gene Polymorphisms in Diffuse Large B-Cell Lymphoma Risk and Overall Survival in an Arab Population: A Case-Control Study.
Al-Khatib SM et al.
Cancers, 2020
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing.
Ruiz-Heredia Y et al.
Haematologica, 2018
Polymorphic variation of inflammation-related genes and risk of non-Hodgkin lymphoma for Uygur and Han Chinese in Xinjiang.
Gu X et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2014
Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies.
Ziakas PD et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 2013
Low prevalence of interleukin-6 haplotypes associated with a decreased risk of type 2 diabetes in Mexican subjects with a family history of type 2 diabetes.
Zamora-Ginez I et al.
Archives of Medical Research, 2013
Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease.
Stoica AL et al.
Journal of Vascular Surgery, 2010
Associations of IL6 polymorphisms with lung function decline and COPD.
He JQ et al.
Thorax, 2009
Cytokine genetic polymorphisms and prostate cancer aggressiveness.
Zabaleta J et al.
Carcinogenesis, 2009
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit.
Henckaerts L et al.
Critical Care Medicine, 2009
Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey.
Saruhan-Direskeneli G et al.
Human Immunology, 2006
The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.
Humphries SE et al.
European Heart Journal, 2001
Select a paper to view details